Sex differences in control of blood pressure: Role of oxidative stress in hypertension in females

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 295, Issue 2, 2008, Pages

  Lopez Ruiz, Arnaldo ^a   Sartori Valinotti, Julio ^a   Yanes, Licy L ^a   Iliescu, Radu ^a   Reckelhoff, Jane F ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

F2 isoprostanes

Indexed keywords

ANTIOXIDANT; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; ESTRADIOL;

BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE; VASODILATATION; AGE; ANIMAL; BLOOD PRESSURE; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; FEMALE; KIDNEY; MALE; METABOLISM; PATHOPHYSIOLOGY;

AGE FACTORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; HUMANS; HYPERTENSION; KIDNEY; MALE; OXIDATIVE STRESS; SEX FACTORS;

EID: 52449101923     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01232.2007     Document Type: Review

References (71)

1. Barella L, Rota C, Stocklin E, Rimbach G. Alpha-tocopherol affects androgen metabolism in male rat. Ann NY Acad Sci 1031: 334-336, 2004.
2. Bayork M, Mann G, Walton M, Eatman D. Effect of enalapril, tempol, and eplerenone on salt-induced hypertension in Dahl salt sensitive rats. Clin Exp Hypertens 28: 121-132, 2006.
3. Block G, Dietrich M, Norkus E, Morrow J, Hudes M, Caan B, Packer L. Factors associated with oxidative stress in human populations. Am J Epidemiol 156: 274-285, 2002.
4. Borras C, Gambini J, Gomez-Cabrera M, Sastre J, Pallardo F, Mann G, Vina J. 17Beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK-1 and ERK2{MAPK}/NFkappaB cascade. Aging Cell 4: 113-118, 2005.
5. Burl VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population. Results From the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25: 305-313, 1995.
6. Burry KA. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. Curr Womens Health Rep 2: 331-332, 2002.
7. Chappell M. Differential effects of sex steroids in young and aged female mREN2. Lewis rats: A model of estrogen and salt-sensitive hypertension. Gend Med 5, Suppl A: S65-S75, 2008.
8. Chen X, Patel K, Connors S, Mendonca M, Welch W, Wilcox C. Acute antihypertensive action with tempol in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 293: H3246-H3253, 2007.
9. Czernichow S, Bertrais S, Blacher J, Galan p Briancon S, Favier A, Safar M, Hercberg S. Effect of supplementation with antioxidants upon long-term risk of hypertension in the SU.VI.MAX study: association with plasma antioxidant levels. J Hypertens 23: 2013-2018, 2005.
10. Dantas A, Mdo CF, Silva-Antonialli M, Tostes T, Fortes Z, Nigro D, Carvalho M. Gender difference in superoxide generation in microvessels of hypertensive rats: role of NAD(P)H-oxidase. Cardiovasc Res 61: 22-29, 2004.
11. Davies S, Zackert W, Luo Y, Cunningham C, Frisard M, Roberts LJ 2nd. Quantification of dinot, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry. Anal Biochem 348: 185-191, 2006.
12. Ebrahimian T, He Y, Schiffrin E, Touyz R. Differential regulation of thioredoxin and NAD(P)H oxidase by angiotensin II in male and female mice. J Hypertens 25: 1263-1271, 2007.
13. Fortepiani LA, Reckelhoff JF. Increasing oxidative stress with molsidomine increases blood pressure in SHR, but not WKY. Am J Physiol Regul Integr Comp Physiol 289: R763-R770, 2005.
14. Fortepiani LA, Reckelhoff JF. Tempol from birth abrogates the sex difference in the depressor response to tempol in SHR. J Hypertens 23: 801-805, 2005.
15. Fortepiani LA, Zhang H, Racusen LC, Roberts LJ II, Reckelhoff JF. Characterization of an animal model of postmenopausal hypertension in SHR. Hypertension 41: 460-463, 2003.
16. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288: 49-57, 2002.
17. Hajiani M, Golestani A, Shariftabrizi A, Rostegar R, Payabvash S, Salmasi A, Dehpour A, Pasalar P. Dose-dependent modulation of systemic lipid peroxidation and activity of antioxidant enzymes by vitamin E in the rat. Redox Rep 13: 60-66, 2008.
18. Hamilton C, Brosnan M, McIntyre M, Graham D, Dominiczak A. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 37: 529-534, 2001.
19. Haywood JR, and Hinojosa-Laborde C. Sexual dimorphism of salt sensitive renal wrap hypertension. Hypertension 30: 67-71, 1997.
20. Helmersson J, Basu S. F(2)-isoprostane and prostaglandin F(2alpha) metabolite excretion rate and day to day variation in healthy humans. Prostaglandins Leukot Essent Fatty Acids 65: 99-102, 2001.
21. Helmersson J, Mattsson P, Basu S. Prostaglandin F(2alpha) metabolite and F2-isoprostane excretion in migraine. Clin Sci (Lond) 102: 39-43, 2002.
22. Herrington DM. The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study. Ann Intern Med 131: 463-466, 1999.
23. Heumuller S, Wind S, Barbosa-Sicard E, Schmidt H, Busse R, Schroder K, Brandes R. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51: 211-217, 2008.
24. Hinojosa-Laborde C, Craig T, Zheng W, Ji H, Haywood J, Sandberg K. Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats. Hypertension 44: 405-409, 2004.
25. Hinojosa-Laborde C, Lange DL, Haywood JR. Role of female sex hormones in the development and reversal of Dahl hypertension. Hypertension 35: 484-489, 2000.
26. Ide T, Tsutsui H, Ohashi N, Hayashidani S, Suematsu N, Tsuchihyasm M, Tamai H, Takeshita A. Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol 22: 1239-1242, 2002.
27. Il'yasova D, Morrow J, Wagenknecht L. Unirary F2-isoprostanes are not associated with increased risk of type 2 diabetes. Obes Res 13: 1638-1644, 2005.
28. Iliescu R, Cucchiarelli VE, Yanes LL, Iles J, Reckelhoff JF. Impact of androgen-induced oxidative stress on blood pressure in male SHR. Am J Physiol Regul Integr Comp Physiol 292: R731-R735, 2007.
29. Iliescu R, Yanes L, Bell W, Dwyer T, Baltatu O, Reckelhoff JF. Role of the renal nerves in control of blood pressure in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 290: R341-R344, 2006.
30. Ji H, Minini S, Mok K, Zheng W, Pesce C, Kim J, Mulroney S, Sandberg K. Gonadal steroid regulation of renal injury in renal wrap hypertension. Am J Physiol Renal Physiol 288: F513-F520, 2005.
31. Ji H, Zheng W, Menini S, Pesce C, Kim J, Wu X, Mulroney S, Sandberg K. Female protection in progressive renal disease is associated with estradiol attenuation of superoxide production. Gend Med 4: 56-71, 2007.
32. Kawanishi H, Hasegawa Y, Nakano D, Ohkita M, Takaoka M, Ohno U, Matsumura Y. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension. Clin Exp Pharmacol Physiol 34: 280-285, 2007.
33. Kelemen M, Vaidya D, Waters D, Howard B, Cobb F, Younes N, Tripputti M, Ouyang P. Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) trial. Atherosclerosis 179: 193-200, 2005.
34. Kesteren PJ, Kooistra T, Lansink M, Kamp GJ, Asscheman H, Gooren LJ, Emeis JJ, Vischer UM, Stehouwer CD. The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning. Thromb Haemost 79: 1029-1033, 1998.
35. Kim J, Alley D, Seeman T, Karlamangla A, Crimmins E. Recent changes in cardiovascular risk factors among women and men. J Womens Health (Larchmt) 15: 734-746, 2006.
36. Kim MK, Sasaki S, Sasazuki S, Okubo S, Hayashi M, Tsigane S. Lack of long-term effect of vitamin C supplementation on blood pressure. Hypertension 40: 797-803, 2002.
37. Kitiyahara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, Welch W, Wilcox CS. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 14: 2775-2782, 2003.
38. Lam K, Lee Y, Hsiao G, Chen S, Yen M. Estrogen therapy replenishes vascular tetrahydrobiopterin and reduces oxidative stress in ovariectomized rats. Menopause 13: 294-302, 2006.
39. Laursen J, Rajagopalan S, Galis Z, Tarpey M, Freeman B, Harrison D. Role of superoxide in angiotensin-II-induced but not catecholamine- induced hypertension. Circulation 95: 588-593, 1997.
40. Levy A, Friedenberg P, Lotan R, Ouyang P, Tripputi M, Higginson L, Cobb F, Tardif J, Bittner V, Howard B. The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women. Diabetes Care 27: 925-930, 2004.
41. Maffei S, Mercuri A, Prontera C, Zucchelli G, Vassalle C. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy. Climacteric 9: 452-458, 2006.
42. McQueen M, Lonn E, Gerstein H, Bosch J, Yusuf S. The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences. Scand J Clin Lab Invest Suppl 240: 143-156, 2005.
43. Miller A, Drummond G, Mast A, Schmidt H, Sobey C. Effect of gender on NADPH-oxidase activity, expression and function in the cerebral circulation: role of estrogen. Stroke 38: 2142-2149, 2007.
44. Palumbo G, Avanzini F, Alli C, Roncaglioni MC, Ronchi E, Christofari M, Capra A, Rossi S, Nosotti L, Costantini C, Cavalera C. Effect of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project-Hypertension study. Am J Hypertens 13: 564-567, 2000.
45. Powledge T. NIH terminates WHI oestrogen-only study. Lancet 363: 870, 2004.
46. Rajagopalan K, Kurz S, Munzel T, Tarpey M, Freeman B, Griendling K, Harrison D. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
47. Reckelhoff JF, Zhang H, Granger JP. Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension 31: 435-439, 1998.
48. Reckelhoff JF, Zhang H, Srivastava K. Gender differences in the development of hypertension in SHR: role of the renin-angiotensin system. Hypertension 35: 480-483, 2000.
49. Reckelhoff JF, Zhang H, Srivastava K, Roberts LJ II, Morrow J, Romero JC. Subpressor doses of angiotensin II increase plasma F2-isoprostanes in rats. Hypertension 35: 476-479, 2000.
50. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension 37: 1199-1208, 2001.
51. Reckelhoff JF, Kellum J. Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging. Life Sci 55: 1895-1902, 1994.
52. Reckelhoff JF, Zhang H, Srivastava K, Granger JP. Gender differences in hypertension in spontaneously rats. Role of androgens and androgen receptor. Hypertension 34: 920-923, 1999.
53. Riazi S, Madala-Halagappa V, Dantas A, Hu X, Ecelbarger C. Sex differences in renal nitric oxide synthase, NAD(P)H oxidase, and blood pressure in obese Zucker rats. Gend Med 43: 214-229, 2007.
54. Rodrigo R, Prat H, Passalacqua W, Araya J, Bachler J. Diminution of oxidative stress through vitamins C and E supplementation associates with blood pressure reduction in essential hypertensives. Clin Sci (Lond). In press.
55. Sartori-Valinotti JC, Iliescu R, Dorsett-Martin W, Yanes LL, Reckelhoff JF. Sex differences in the pressor response to angiotensin II on normal or high salt diet when the endogenous renin-angiotensin system is blocked. Hypertension 51: 1170-1176, 2008.
56. Sartori-Valinotti JC, Iliescu R, Fortepiani L, Yanes L, Reckelhoff J. Sex differences in oxidative stress and the impact on blood pressure control and cardiovascular disease. Clin Exp Pharm Physiol 34: 938-945, 2007.
57. Sato K, Dohi Y, Kojima M, Miyagswa K, Tagase H, Katada E, Suzuki S. Effects of ascorbic acid on ambulatory blood pressure in elderly patients with refractory hypertension. Arnzneittelforschung 56: 535-560, 2006.
58. Schnackenberg C, Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-isoprostaglandin F2alpha. Hypertension 33: 424-428, 1999.
59. Schneider M, Delles C, Schmidt B, Oehmer S, Schwarz T, Schmieder R, John S. Superoxide scavenging effect of N-acetylcysteine and vitamin C in subject with essential hypertension. Am J Hypertens 18: 1111-1117, 2005.
60. Schutte A, Huisman H, Oosthuizen W, vanRooyen J, Jerling J. Cardiovascular effects of oral supplementation of vitamin C, E and frolic acid in young healthy males. Int J Vitam Nutr Res 74: 285-293, 2004.
61. Sowers M, McConnell D, Jannausch M, Randolph J, Brook R, Gold E, Crawford S, Lasley B. Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress. Clin Endocrinol (Oxf) 68: 806-813, 2008.
62. Sullivan J, Sasser J, Pollock J. Sexual dimorphism in oxidant status in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 292: R764-R768, 2007.
63. Tatchum-Talom R, Eyster K, Martin D. Sexual dimorphism in angiotensin II-induced hypertension and vascular alterations. Can J Physiol Pharmacol 83: 413-422, 2005.
64. Taylor N, Glocka P, Liang M, Cowley AC Jr. NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt sensitive hypertension in Dahl salt-sensitive rats. Hypertension 47: 692-698, 2006.
65. Tian N, Moore R, Bradley S, Rose R, Gu J, Hughson M, Manning RD Jr. Interaction between oxidative stress and inflammation in salt sensitive hypertension. Am J Physiol Heart Circ Physiol 293: H3388-H3395, 2007.
66. Ward N, Wu J, Clarke M, Puddey I, Burke V, Croft K, Hodgson J. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J Hypertens 25: 227-234, 2007.
67. Ward W, Qi W, VanRemmen H, Zackert W, Roberts JL 2nd, Richardson A. Effects of age and caloric restriction on lipid peroxidation: measurement of oxidative stress by F2-isoprostane levels. J Gerontol A Biol Sci Med Sci 60: 847-851, 2005.
68. Wiinber N, Hoegholm A, Christensen H, Bang L, Mikkelsen K, Nielsen P, Svendsen T, Kampmann J, Madsen N, Bentzon M. 24-h Ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 8: 978-986, 1995.
69. Wu Z, Maric C, Roesch D, Zheng W, Verbalis J, Sandberg K. Estrogen regulates adrenal angiotensin AT1 receptors by modulating AT1 receptor translation. Endocrinology 144: 3251-3261, 2003.
70. Xu H, Bian X, Watts S, Hlavacova A. Activation of vascular BK channel by tempol in DOCA-salt hypertensive rats. Hypertension 46: 1154-1162, 2005.
71. Yanes L, Romero D, Iliescu R, Cucchiarelli V, Fortepiani L, Santacruz F, Bell W, Zhang H, Reckelhoff J. Systemic arterial pressure response to two wk of tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress. Am J Physiol Regul Integr Comp Physiol 288: R229-R233, 2005.